$JAGX

$6.40▲ +35.9% YTD

9 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History

CP $6.40▲ +35.9%Oct 6, 2026 · ThinkSabio Blog

$JAGX - Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference…

News

JAGX ▼ -6.6% - Jaguar Health, Inc.

CP $3.66▲ -6.6%Oct 3, 2026 · ThinkSabio Blog

$JAGX - Jaguar Health Announces a Special Stock Dividend…

News

JAGX ▼ -0.2% - Jaguar Health, Inc.

CP $5.98▲ -0.2%Sep 29, 2026 · ThinkSabio Blog

$JAGX - Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofeleme…

News

JAGX ▲ +1652.1% - Jaguar Health, Inc.

CP $46.78▲ +1652.1%Sep 22, 2026 · ThinkSabio Blog

$JAGX highs ah…

News

JAGX ▲ +59.6% - Jaguar Health, Inc.

CP $4.26▲ +59.6%Sep 22, 2026 · ThinkSabio Blog

$JAGX pop CB Halt…

News

JAGX ▲ +9.7% - Jaguar Health, Inc.

CP $2.93▲ +9.7%Sep 22, 2026 · ThinkSabio Blog

$JAGX - Jaguar Health Receives Fee Waivers from FDA…

News

JAGX ▼ -9.4% - Jaguar Health, Inc.

CP $0.29▲ -9.4%Sep 15, 2026 · ThinkSabio Blog

$JAGX - Jaguar Health, Inc. Announces Reverse Stock Split…

News

JAGX ▼ -15.0% - Jaguar Health, Inc.

CP $0.51▲ -15.0%Sep 8, 2026 · ThinkSabio Blog

$JAGX - Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in…

News

JAGX ▲ +4.3% - Jaguar Health, Inc.

CP $0.72▲ +4.3%Sep 4, 2026 · ThinkSabio Blog

$JAGX - Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)…